Quintiles invests £3m in biomarker R&D firm; establishes BPO centre in China
Quintiles has invested £3m ($4.6m) in a new UK-based biomarker R&D company in a continuation of its efforts to build in the field of personalised medicines.
Archives for January 18, 2012
US DoD awards CMO Paragon Bioservices $15m vaccine deal
CMO Paragon Bioservices has won a $15m DoD contract to develop a large-scale mammalian process for a trivalent filovirus vaccine.